Top compounds associated with response to EIF3C


Feature Type Standardized
Nominal ANOVA
mRNA myricetin CTRPv2 pan-cancer AAC -0.025 0.5
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA paclitaxel gCSI pan-cancer AAC -0.034 0.5
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.022 0.5
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.029 0.5
mRNA masitinib CTRPv2 pan-cancer AAC 0.023 0.5
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.022 0.5
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.025 0.5
Download CSV